We are live on
!
Find out more
SCM
Scopia Capital Management Portfolio holdings
AUM
$112M
1-Year Est. Return
48.41%
This Fund
S&P 500
This Quarter
Est. Return
-0.89%
1 Year Est. Return
+48.41%
3 Year Est. Return
+58.7%
5 Year Est. Return
+80.15%
10 Year Est. Return
+533.22%
AUM
$926M
AUM Growth
+$189M
(+26%)
Cap. Flow
+$18.4M
Cap. Flow
% of AUM
1.99%
Top 10 Holdings %
Top 10 Hldgs %
84.92%
Holding
19
New
5
Increased
4
Reduced
6
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EnerSys
ENS
|
+$49.7M |
| 2 |
Sonos
SONO
|
+$44.3M |
| 3 |
Cheesecake Factory
CAKE
|
+$24.7M |
| 4 |
Mohawk Industries
MHK
|
+$4.36M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$4.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$48.3M |
| 2 |
Zurn Elkay Water Solutions
ZWS
|
+$22.1M |
| 3 |
SPR
Spirit AeroSystems
SPR
|
+$18.5M |
| 4 |
Xometry
XMTR
|
+$17.5M |
| 5 |
KBR
KBR
|
+$2.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 41.41% |
| 2 | Technology | 29.32% |
| 3 | Miscellaneous | 19.18% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Energy | 1.52% |
Similar funds
SWM
TFS
WAM
CS
BU
TBFA
VDC
RQS
Scopia Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Scopia Capital Management held 19 positions worth $926M, up 26% from $737M the previous quarter. Its ten largest holdings account for 85% of the portfolio.
Scopia Capital Management's Q3 2021 filing shows 5 new, 4 increased, 6 reduced and 2 closed positions. Its largest new stake was EnerSys: 560,083 shares worth $41.7M. The largest sale was United Therapeutics, an estimated $48.3M.
By sector, the portfolio is most concentrated in Industrials at 41% of assets, down from 53% a quarter earlier, followed by Technology and Miscellaneous.
- Scopia Capital Management's largest Q3 2021 buy was EnerSys: 560,083 shares worth $41.7M.
- Scopia Capital Management added most to Mohawk Industries in Q3 2021, an estimated $4.36M increase.
- Scopia Capital Management's biggest Q3 2021 reduction was Zurn Elkay Water Solutions, cutting an estimated $22.1M.
- Scopia Capital Management fully exited United Therapeutics in Q3 2021, selling an estimated $48.3M.
- Scopia Capital Management's ten largest holdings make up 85% of its $926M portfolio in Q3 2021.
- Scopia Capital Management opened 5 new positions and closed 2 in Q3 2021.
- Scopia Capital Management's portfolio value rose 26% quarter-over-quarter to $926M.
Based on Scopia Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.